<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03256383</url>
  </required_header>
  <id_info>
    <org_study_id>276</org_study_id>
    <nct_id>NCT03256383</nct_id>
  </id_info>
  <brief_title>Plan for Testing Fingerstick Bloods on Magellan Systems</brief_title>
  <official_title>Plan for Testing Fingerstick Bloods on Magellan Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Magellan Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Magellan Diagnostics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to supplement our internal data that demonstrates the continued performance of
      capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra
      (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II
      instrument in development.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 31, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lead poisoning</measure>
    <time_frame>1 day</time_frame>
    <description>&gt;10ug/dL lead in whole blood is considered lead poisoning These measurements will be taken to compare the fingerstick data collected in the field with data received through reference method</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Lead Poisoning</condition>
  <arm_group>
    <arm_group_label>Adult</arm_group_label>
    <description>Patients aged 18+ years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children 7 - 17</arm_group_label>
    <description>Patients aged 7 - 17 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children &lt;7</arm_group_label>
    <description>Patients aged under 7 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lead testing</intervention_name>
    <description>Fingerstick</description>
    <arm_group_label>Adult</arm_group_label>
    <arm_group_label>Children 7 - 17</arm_group_label>
    <arm_group_label>Children &lt;7</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adults and children up to 18 years of age who are at risk of lead exposure, pregnant women
        who are at risk of lead exposure,
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects who consent to a capillary blood collection

        Exclusion Criteria:

          -  Patients are not currently taking chelating agents, e.g., penicillamine, succimer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Rappo, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Lufkin</last_name>
    <phone>978-248-4963</phone>
    <email>Catherine.Lufkin@magellandx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric Associates, Inc.</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Rappo, MD</last_name>
      <phone>508-584-1210</phone>
      <email>prappo@pediatricassociatesbrockton.com</email>
    </contact>
    <investigator>
      <last_name>Peter Rappo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatrics Associates, Inc</name>
      <address>
        <city>Hanson</city>
        <state>Massachusetts</state>
        <zip>02341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Rappo, MD</last_name>
      <email>prappo@pediatricassociatesbrockton.com</email>
    </contact>
    <investigator>
      <last_name>Peter Rappo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatrics Associates, Inc</name>
      <address>
        <city>West Bridgewater</city>
        <state>Massachusetts</state>
        <zip>02379</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Rappo, MD</last_name>
      <phone>508-584-1210</phone>
      <email>prappo@pediatricassociatesbrockton.com</email>
    </contact>
    <investigator>
      <last_name>Peter Rappo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2017</study_first_submitted>
  <study_first_submitted_qc>August 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Lead Poisoning</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

